In the 1980s, according to the basic principle of ELISA technology, foreign researchers established a solid-phase enzyme-linked immunospot technology for detecting specific antibody-secreting cells and cytokines-secreting cells in vitro. TOPBIOTECH uses specific monoclonal antibodies to capture cytokines that are locally produced by stimulated cells.